Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.

Dinan, Michaela A

Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009. [electronic resource] - JAMA oncology May 2015 - 158-66 p. digital

Publication Type: Journal Article; Observational Study; Research Support, U.S. Gov't, P.H.S.

2374-2445

10.1001/jamaoncol.2015.43 doi


Age Factors
Aged
Aged, 80 and over
Biomarkers, Tumor--genetics
Breast Neoplasms--ethnology
Chemotherapy, Adjuvant
Chi-Square Distribution
Female
Gene Expression Profiling--methods
Genetic Predisposition to Disease
Guideline Adherence
Healthcare Disparities
Humans
Medicare--statistics & numerical data
Multivariate Analysis
Neoplasm Recurrence, Local
Neoplasm Staging
Odds Ratio
Phenotype
Practice Guidelines as Topic
Practice Patterns, Physicians'--trends
Predictive Value of Tests
Racial Groups
Residence Characteristics
Retrospective Studies
Risk Assessment
Risk Factors
SEER Program
Time Factors
Treatment Outcome
United States--epidemiology